Saha N, Banerjee K K
Division of Immunology and Vaccine Development, National Institute of Cholera and Enteric Diseases, Calcutta, India.
J Bacteriol. 1995 Feb;177(3):758-64. doi: 10.1128/jb.177.3.758-764.1995.
The carbohydrate-binding specificity of the cell-free hemagglutinin (HA) of Vibrio cholerae (K.K. Banerjee, A.N. Ghose, K. Datta-Roy, S.C. Pal, and A.C. Ghose, Infect. Immun.58:3698-3705, 1990) was studied by using glycoconjugates with defined sugar sequences. The HA was not inhibited by simple sugars including glucobiose, galabiose, and their N-acetylated derivatives. The hemagglutination of rabbit erythrocytes by the HA was inhibited moderately by fetuin, calf thyroglobulin, and human alpha 1-acid glycoprotein, all of which contain multiple asparagine-linked complex-type oligosaccharide units alone or in combination with serine/threonine-linked oligosaccharide units. The inhibitory potencies of the glycoproteins increased approximately 10-fold following removal of the terminal sialic acid and were completely destroyed by exhausative proteolysis. The HA agglutinated phosphatidylcholine liposomes containing GM1-ganglioside or its asialo-derivative in the presence of Ca2+ ions. The association constants of the complexes of the HA with asialofetuin, asialothyroglobulin, GM1-ganglioside, and asialo-GM1-ganglioside were determined by an enzyme-linked immunosorbent assay-based assay and found to be 1.7 x 10(7) M-1, 1.5 x 10(7) M-1, 1.8 x 10(7) M-1, and 2.4 x 10(7) M-1, respectively. Studies using chemically modified glycoproteins and plant lectins with defined sugar specificity revealed that the HA recognized the terminal beta 1-galactosyl moiety of these glycoconjugates. There was no evidence for the presence of an extended carbohydrate-binding domain in the HA molecule or a preference of the HA for a complex, branched oligosaccharide structure. Similar to the mechanisms proposed for the binding of cholera toxin and Shiga toxin to glycolipids and neoglycoproteins, the strong interaction of V. cholerae cell-free HA with glycoconjugates appeared to be a consequence of multiple weak binding to terminal beta1-galactosyl moieties of the glycoproteins or glycolipids.
利用具有特定糖序列的糖缀合物,对霍乱弧菌无细胞血凝素(HA)(K.K. 班纳吉、A.N. 戈斯、K. 达塔 - 罗伊、S.C. 帕尔和A.C. 戈斯,《感染与免疫》58:3698 - 3705,1990年)的碳水化合物结合特异性进行了研究。该HA不受包括葡二糖、半乳糖二糖及其N - 乙酰化衍生物在内的单糖抑制。胎球蛋白、小牛甲状腺球蛋白和人α1 - 酸性糖蛋白对HA介导的兔红细胞凝集有中等程度的抑制作用,这些糖蛋白均单独或与丝氨酸/苏氨酸连接的寡糖单元组合含有多个天冬酰胺连接的复合型寡糖单元。去除末端唾液酸后,这些糖蛋白的抑制效力增加约10倍,并通过彻底的蛋白酶解完全破坏。在Ca2 + 离子存在下,HA能凝集含有GM1 - 神经节苷脂或其去唾液酸衍生物的磷脂酰胆碱脂质体。通过基于酶联免疫吸附测定的方法测定了HA与去唾液酸胎球蛋白、去唾液酸甲状腺球蛋白、GM1 - 神经节苷脂和去唾液酸GM1 - 神经节苷脂复合物的缔合常数,分别为1.7×10(7) M-1、1.5×10(7) M-1、1.8×10(7) M-1和2.4×10(7) M-1。使用化学修饰的糖蛋白和具有特定糖特异性的植物凝集素进行的研究表明,HA识别这些糖缀合物的末端β1 - 半乳糖基部分。没有证据表明HA分子中存在扩展的碳水化合物结合结构域,也没有证据表明HA对复杂的分支寡糖结构有偏好。与霍乱毒素和志贺毒素与糖脂和新糖蛋白结合所提出的机制类似,霍乱弧菌无细胞HA与糖缀合物的强相互作用似乎是与糖蛋白或糖脂末端β1 - 半乳糖基部分多次弱结合的结果。